Fibrinolysis induced clinical improvement in a patient with multiple sclerosis exacerbation.
Multiple Sclerosis and Related Disorders(2020)
摘要
•The MS patient with disease exacerbation was treated with fibrinolytic therapy.•In 5.4 hours after fibrinolysis, his disability improved from NIHSS score 9 to 1.•The symptomatic enhancing MS lesion had restricted diffusion on brain MRI.•Fibrin is a potential therapeutic target in a subset of people with MS.
更多查看译文
关键词
Multiple sclerosis,Relapsing-remitting,MRI,DWI,Tissue plasminogen activator,MS exacerbation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要